An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

C.M. Sanders; C.A. Langley; J. Persaud; J.F. Marriott; K.A. Wilson

doi:10.1211/096176703777341345

Abstract

Poster session
- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form
- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent
- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity
- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol
- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

Original language	English
Pages (from-to)	R37
Number of pages	1
Journal	International Journal of Pharmacy Practice
Volume	11
Issue number	S1
DOIs	https://doi.org/10.1211/096176703777341345
Publication status	Published - Sept 2003
Event	British Pharmaceutical Conference 2003 - Harrogate, United Kingdom Duration: 15 Sept 2003 → 17 Sept 2003

Access to Document

10.1211/096176703777341345

Cite this

@article{803721748ea9491b8a16ab9c510ca287,

title = "An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients",

abstract = "Poster session- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination",

author = "C.M. Sanders and C.A. Langley and J. Persaud and J.F. Marriott and K.A. Wilson",

year = "2003",

month = sep,

doi = "10.1211/096176703777341345",

language = "English",

volume = "11",

pages = "R37",

journal = "International Journal of Pharmacy Practice",

issn = "0961-7671",

publisher = "Pharmaceutical Press",

number = "S1",

note = "British Pharmaceutical Conference 2003 ; Conference date: 15-09-2003 Through 17-09-2003",

}

TY - JOUR

T1 - An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

AU - Sanders, C.M.

AU - Langley, C.A.

AU - Persaud, J.

AU - Marriott, J.F.

AU - Wilson, K.A.

PY - 2003/9

Y1 - 2003/9

N2 - Poster session- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

AB - Poster session- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

UR - https://onlinelibrary.wiley.com/doi/abs/10.1211/096176703777341345

U2 - 10.1211/096176703777341345

DO - 10.1211/096176703777341345

M3 - Conference abstract

SN - 0961-7671

VL - 11

SP - R37

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

IS - S1

T2 - British Pharmaceutical Conference 2003

Y2 - 15 September 2003 through 17 September 2003

ER -

An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

Abstract

Access to Document

Other files and links

Fingerprint

Financial consequences of one-stop dispensing at Birmingham Children's Hospital

Postgraduate training offered to primary care pharmacists by schools of pharmacy - changes over the last five years

Training and development needs of PCT strategic level pharmacists

Cite this

An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

Abstract

Access to Document

Other files and links

Fingerprint

Research output

Financial consequences of one-stop dispensing at Birmingham Children's Hospital

Postgraduate training offered to primary care pharmacists by schools of pharmacy - changes over the last five years

Training and development needs of PCT strategic level pharmacists

Cite this